Breast cancer diagnosis and staging in Chile: A non-randomized survey-based study to assess frequency and delays
Biopsy in Chile is the test of choice for diagnostic confirmation in breast cancer. Other tests are requested regardless of the diagnosis stage, contrary to the recommendations of clinical guidelines. Cancer prognosis is crucial, especially in countries with greater inequalities.
Authors
- Alexandra Obach (ORCID: https://orcid.org/0000-0002-7412-4159)
- Carla Campaña (ORCID: https://orcid.org/0000-0002-3525-011X)
- Marcela Oyarte (ORCID: https://orcid.org/0000-0003-3757-4262)
- Báltica Cabieses (ORCID: https://orcid.org/0000-0003-0756-1954)
Institutions
- Universidad del Desarrollo (CL)
- Agencia Nacional de Investigación y Desarrollo (CL)
- Dirección de Investigación y Desarrollo (CL)
Publication Details
- Journal
- Medwave
- Published
- 2024-10-14
- DOI
- https://doi.org/10.5867/medwave.2024.09.2801
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00